↓ Skip to main content

A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer

Overview of attention for article published in Journal of Translational Medicine, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
twitter
3 X users
patent
3 patents

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
115 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer
Published in
Journal of Translational Medicine, August 2012
DOI 10.1186/1479-5876-10-157
Pubmed ID
Authors

Lana E Kandalaft, Daniel J Powell, George Coukos

Abstract

In spite of increased rates of complete response to initial chemotherapy, most patients with advanced ovarian cancer relapse and succumb to progressive disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Unknown 113 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 19%
Researcher 21 18%
Student > Master 14 12%
Student > Bachelor 11 10%
Other 7 6%
Other 17 15%
Unknown 23 20%
Readers by discipline Count As %
Medicine and Dentistry 24 21%
Agricultural and Biological Sciences 24 21%
Biochemistry, Genetics and Molecular Biology 16 14%
Immunology and Microbiology 12 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 8 7%
Unknown 27 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2022.
All research outputs
#2,418,597
of 25,377,790 outputs
Outputs from Journal of Translational Medicine
#425
of 4,637 outputs
Outputs of similar age
#15,383
of 179,557 outputs
Outputs of similar age from Journal of Translational Medicine
#6
of 55 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,637 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,557 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.